| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
ORIGINAL RESEARCH COMMUNICATION |
1 From the Department of Obstetrics and Gynecology, University of Wisconsin School of Medicine and Public Health, Madison, WI (LDW), and the Department of Nutritional Sciences, University of Wisconsin-Madison, Madison, WI (ACW and DAS)
Background:Conjugated linoleic acid (CLA) has been shown to be an effective supplement for reducing fat mass in animals, whereas results in humans have been inconsistent.
Objective:This is a meta-analysis of human studies in which CLA was provided as a dietary supplement to test its efficacy in reducing fat mass.
Design:We searched the PubMed database (National Library of Medicine, Bethesda, MD) and references from the resulting search to identify studies in which CLA was provided to humans in randomized, double-blinded, placebo-controlled trials and in which body composition was assessed by using a validated technique.
Results:We identified 18 eligible studies. Of these, 3 were single-isomer studies, and results comparing CLA isomers were inconclusive. We compared the length of treatment by using studies in which a mixture of purified isomers were used and those in which purified trans-10,cis-12 isomers were used. This comparison indicated that the effect of CLA was linear for up to 6 mo and then slowly approached an asymptote at 2 y. An analysis of the dose effect indicated that fat loss compared with placebo was –0.024 kg · g CLA–1 · wk–1 (P = 0.03). After adjustment to the median dose of 3.2 g CLA/d, CLA was effective and produced a reduction in fat mass for the CLA group alone (0.05 ± 0.05 kg/wk; P < 0.001) and for the CLA group compared with placebo (0.09 ± 0.08 kg/wk; P < 0.001)
Conclusion:Given at a dose of 3.2 g/d, CLA produces a modest loss in body fat in humans.
Key Words: Body composition • obesity • weight loss • conjugated linoleic acid
This article has been cited by other articles:
|
|
 |
|
  R. Gervais, J. W. McFadden, A. J. Lengi, B. A. Corl, and P. Y. Chouinard Effects of intravenous infusion of trans-10, cis-12 18:2 on mammary lipid metabolism in lactating dairy cows J Dairy Sci, October 1, 2009; 92(10): 5167 - 5177. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. E Norris, A. L Collene, M. L Asp, J. C Hsu, L.-F. Liu, J. R Richardson, D. Li, D. Bell, K. Osei, R. D Jackson, et al. Comparison of dietary conjugated linoleic acid with safflower oil on body composition in obese postmenopausal women with type 2 diabetes mellitus Am. J. Clinical Nutrition, September 1, 2009; 90(3): 468 - 476. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Raff, T. Tholstrup, S. Toubro, J. M. Bruun, P. Lund, E. M. Straarup, R. Christensen, M. B. Sandberg, and S. Mandrup Conjugated Linoleic Acids Reduce Body Fat in Healthy Postmenopausal Women J. Nutr., July 1, 2009; 139(7): 1347 - 1352. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Kennedy, A. Overman, K. LaPoint, R. Hopkins, T. West, C.-C. Chuang, K. Martinez, D. Bell, and M. McIntosh Conjugated linoleic acid-mediated inflammation and insulin resistance in human adipocytes are attenuated by resveratrol J. Lipid Res., February 1, 2009; 50(2): 225 - 232. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. E. Bauman, J. W. Perfield II, K. J. Harvatine, and L. H. Baumgard Regulation of Fat Synthesis by Conjugated Linoleic Acid: Lactation and the Ruminant Model J. Nutr., February 1, 2008; 138(2): 403 - 409. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
